Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02146833
Title Study of Selinexor (KPT-330) in Metastatic Castrate Resistant Prostate Adenocarcinoma
Acronym SHIP
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
M.D. Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field